River Road Asset Management, LLC Haemonetics Corp Transaction History

River Road Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$63.3 - $78.66 $23.7 Million - $29.5 Million	-374,660 Reduced 79.94%	93,995 $6.96 Million
Q2 2022 Jul 20, 2022	SELL	$49.27 - $66.08 $23.3 Million - $31.3 Million	-473,686 Reduced 50.27%	468,655 $30.5 Million
Q1 2022 May 12, 2022	BUY	$43.77 - $63.22 $6.42 Million - $9.27 Million	146,641 Added 18.43%	942,341 $59.6 Million
Q4 2021 Feb 01, 2022	BUY	$49.55 - $74.59 $19.2 Million - $28.9 Million	386,813 Added 94.6%	795,700 $42.2 Million
Q3 2021 Nov 12, 2021	BUY	$57.6 - $70.59 $6.7 Million - $8.21 Million	116,271 Added 39.74%	408,887 $28.9 Million
Q2 2021 Aug 10, 2021	BUY	$51.81 - $118.56 $15.2 Million - $34.7 Million	292,616 New	292,616 $19.5 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.54B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of River Road Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on River Road Asset Management, LLC with notifications on news.